BlackRock’s Ensysce Biosciences ENSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145 | Hold |
65
| – | – | ﹤0.01% | 5333 |
|
|
2025
Q1 | $166 | Buy |
65
+1
| +2% | +$3 | ﹤0.01% | 5326 |
|
|
2024
Q4 | $521 | Sell |
64
-1
| -2% | -$8 | ﹤0.01% | 5270 |
|
|
2024
Q3 | $234 | Hold |
65
| – | – | ﹤0.01% | 5122 |
|
|
2024
Q2 | $494 | Hold |
65
| – | – | ﹤0.01% | 5168 |
|
|
2024
Q1 | $770 | Hold |
65
| – | – | ﹤0.01% | 5151 |
|
|
2023
Q4 | $1.03K | Hold |
65
| – | – | ﹤0.01% | 5192 |
|
|
2023
Q3 | $1.35K | Hold |
65
| – | – | ﹤0.01% | 5246 |
|
|
2023
Q2 | $1.76K | Hold |
65
| – | – | ﹤0.01% | 5288 |
|
|
2023
Q1 | $4.74K | Hold |
65
| – | – | ﹤0.01% | 5291 |
|
|
2022
Q4 | $8.78K | Hold |
65
| – | – | ﹤0.01% | 5395 |
|
|
2022
Q3 | $50K | Hold |
65
| – | – | ﹤0.01% | 5262 |
|
|
2022
Q2 | $203K | Hold |
65
| – | – | ﹤0.01% | 4930 |
|
|
2022
Q1 | $267K | Buy |
+65
| New | +$267K | ﹤0.01% | 4951 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5600 |
|